Canada - TSX:CRRX - CA14173C1059 - Common Stock
The current stock price of CRRX.CA is 3.5 CAD. In the past month the price decreased by -2.51%. In the past year, price increased by 84.21%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| PCRX.CA | PHARMACORP RX INC | N/A | 53.96M | ||
| WOLF.CA | GREY WOLF ANIMAL HEALTH CORP | 66.5 | 45.47M |
CareRx Corp. engages in the provision of pharmacy and other healthcare services. The company is headquartered in Toronto, Ontario and currently employs 1,423 full-time employees. The company went IPO on 2002-09-04. The firm serves approximately 88,000 residents in approximately 1,450 senior and other congregate care communities, including long-term care homes, retirement homes, assisted living facilities, and group homes. The company has a network of pharmacy fulfillment centers located across the country. The company supports its home care partners by providing solutions for the supply of chronic medication. The company uses technology that automates the preparation and verification of multi-dose compliance packaging of medication, providing the safety and adherence for individuals with complex medication regimens. Revicare by CareRx is a distributor of medical supplies and continence care management products to residents in retirement and supportive living communities. The firm works with its home operator partners to promote resident health, staff education, and medication system quality and efficiency.
CARERX CORP
320 Bay St. Suite 1200
TORONTO ONTARIO M4R 1K8 CA
CEO: David Murphy
Employees: 1466
Phone: 16473614499
CareRx Corp. engages in the provision of pharmacy and other healthcare services. The company is headquartered in Toronto, Ontario and currently employs 1,423 full-time employees. The company went IPO on 2002-09-04. The firm serves approximately 88,000 residents in approximately 1,450 senior and other congregate care communities, including long-term care homes, retirement homes, assisted living facilities, and group homes. The company has a network of pharmacy fulfillment centers located across the country. The company supports its home care partners by providing solutions for the supply of chronic medication. The company uses technology that automates the preparation and verification of multi-dose compliance packaging of medication, providing the safety and adherence for individuals with complex medication regimens. Revicare by CareRx is a distributor of medical supplies and continence care management products to residents in retirement and supportive living communities. The firm works with its home operator partners to promote resident health, staff education, and medication system quality and efficiency.
The current stock price of CRRX.CA is 3.5 CAD. The price decreased by -2.78% in the last trading session.
CARERX CORP (CRRX.CA) has a dividend yield of 2.17%. The yearly dividend amount is currently 0.
CRRX.CA has a ChartMill Technical rating of 9 out of 10 and a ChartMill Fundamental rating of 4 out of 10.
CARERX CORP (CRRX.CA) operates in the Consumer Staples sector and the Consumer Staples Distribution & Retail industry.
CARERX CORP (CRRX.CA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.03).
ChartMill assigns a technical rating of 9 / 10 to CRRX.CA. When comparing the yearly performance of all stocks, CRRX.CA is one of the better performing stocks in the market, outperforming 83.44% of all stocks.
ChartMill assigns a fundamental rating of 4 / 10 to CRRX.CA. CRRX.CA scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
Over the last trailing twelve months CRRX.CA reported a non-GAAP Earnings per Share(EPS) of -0.03. The EPS increased by 72.73% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -0.83% | ||
| ROE | -2.09% | ||
| Debt/Equity | 0.85 |
12 analysts have analysed CRRX.CA and the average price target is 4.37 CAD. This implies a price increase of 24.9% is expected in the next year compared to the current price of 3.5.
For the next year, analysts expect an EPS growth of 240.18% and a revenue growth 1.67% for CRRX.CA